RE: RE: re. efficacy target from jenniferStooge,
I'm not sure that Endo can withhold the results so as to entertain a conference next May. This is material information which the shareholders are entitled to. BNC was entilted to their milestone payment now. Today's BNC milestone NR concludes that the results have been analyzed, and have met the FDA targets. This is all the info that the BNC shareholders are entitled to.
Having said that, the Endo shareholders are entiltled those result. The urologist are not, unless of course they are Endo shareholders.
Expect some form of an Endo NR very soon. It may not have all the details we want, but it must speak to the results and this NR must happen soon.
TC9